CGFCX
Price
$73.94
Change
-$0.24 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
VLLIX
Price
$51.22
Change
-$0.89 (-1.71%)
Updated
Jun 2 closing price
Net Assets
468.91M
Interact to see
Advertisement

CGFCX vs VLLIX

Header iconCGFCX vs VLLIX Comparison
Open Charts CGFCX vs VLLIXBanner chart's image
CGFCX vs VLLIX Comparison Chart in %
View a ticker or compare two or three
VS
CGFCX vs. VLLIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGFCX is a Hold and VLLIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGFCX has more cash in the bank: 338B vs. VLLIX (469M). CGFCX (0.00) and VLLIX (0.00) have matching dividends . CGFCX was incepted earlier than VLLIX: CGFCX (24 years) vs VLLIX (11 years). CGFCX (1.39) is less costly to investors than VLLIX (1.22). VLLIX is a more actively managed with annual turnover of: 38.00 vs. CGFCX (32.00). CGFCX has a lower initial minimum investment than VLLIX: CGFCX (250) vs VLLIX (100000). VLLIX annual gain was more profitable for investors over the last year : 26.22 vs. CGFCX (12.05). VLLIX return over 5 years is better than : 30.60 vs. CGFCX (14.62).
CGFCXVLLIXCGFCX / VLLIX
Total Expense Ratio1.390.88158%
Annual Report Gross Expense Ratio1.391.22114%
Fund Existence24 years11 years-
Gain YTD10.09213.79773%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets338B469M72,068%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.0526.2246%
Returns for 3 years44.23108.8941%
Returns for 5 years14.6230.6048%
Returns for 10 years87.7097.3890%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDY618.819.34
+1.53%
Teledyne Technologies
SKLZ10.040.04
+0.40%
Skillz
RAY3.37-0.01
-0.30%
Raytech Holding Limited
ITRI83.84-0.95
-1.12%
Itron
EVMN19.82-2.35
-10.60%
Evommune Inc.